Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UPF3B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.004 |
mRNA | HNRNPF | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
mRNA | ZNF282 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.004 |
mRNA | DDX54 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
mRNA | JADE1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
mRNA | SLC43A1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
mRNA | SLC25A16 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
mRNA | IKBIP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | WBP2NL | CTRPv2 | pan-cancer | AAC | -0.083 | 0.004 |